Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00040833 · ClinicalTrials.gov registry record · Phase 2

Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer

A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
Phase 2
Development phase

NCT00040833: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00040833 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00040833, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
Phase 2
Development phase

Study Summary

RATIONALE: Acupuncture and acupressure may help relieve moderate or severe pain associated with stage III or stage IV pancreatic cancer. PURPOSE: Phase II trial to study the effectiveness of acupuncture and accupressure in treating patients who have moderate or severe pain associated with stage III or stage IV pancreatic cancer.

Interventions

  • PROCEDURE pain therapy
  • PROCEDURE complementary or alternative medicine procedure

Trial Details

FieldValue
Start Date 2002-02
Est. Completion 2003-06
Phase Phase 2

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00040833

The ClinicalTrials.gov registry entry for NCT00040833 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which pain therapy is the first listed.

NCT00040833 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00040833 about?

NCT00040833 is a clinical study titled "Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer". RATIONALE: Acupuncture and acupressure may help relieve moderate or severe pain associated with stage III or stage IV pancreatic cancer. PURPOSE: Phase II trial to study the effectiveness of acupuncture and accupressure in treating patients who have moderate or severe pain associated with stage III...

What is the current status of trial NCT00040833?

This trial is currently completed. It is a Phase 2 study. The study started on 2002-02. Estimated completion is 2003-06.

What interventions are being tested in trial NCT00040833?

The interventions under investigation include: pain therapy (PROCEDURE), complementary or alternative medicine procedure (PROCEDURE).

Who is sponsoring clinical trial NCT00040833?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.